Thursday May 16
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
A changing of the guard at Switzerland's two biggest drugmakers is fuelling talk that Novartis may finally sell its multi-billion-dollar stake in cross-town rival Roche, potentially unlocking value for both sets of shareholders.
Sun May 12, 2013
Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
Boulder, Colorado-based Array BioPharma Inc. is a $594M market cap biopharmaceutical company that discovers, develops and commercializes targeted small molecule drugs to treat cancers and inflammatory diseases.
Fri May 10, 2013
Novartis: FDA Approves Ilaris for Serious Form of Childhood Arthritis
Novartis AG said the U.S. Food and Drug Administration approved Ilaris for the treatment of active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis.
Tue May 07, 2013
The Boulder County Business Report
Array reports decline in revenue, income
Cancer drug research company Array BioPharma Inc. reported lower revenue and higher losses for the most recent quarter compared with the same period a year ago.
Mon May 06, 2013
MDT, HLF, OREX, and NVS Early Briefing and Review
The Affordable Care Act , which was upheld by the Supreme Court last year, is expected to result in higher costs for the healthcare industry.
Novartis to Cut 300 Jobs in OTC Plant Restructuring After Form 483
Novartis says both its Swiss plant and third-parties will support its consumer health lines as it restructures its Nebraska facility following a FDA Form 483.
Thu May 02, 2013
Lanai owner Larry Ellison invests in Proteus Digital Health
What many people may not know about Lanai majority owner Larry Ellison , is that in addition to real estate, technology and sailing, the Oracle Corp.
Mylan profit falls on acquisition costs
Mylan is the world's third-largest generic-drug maker by sales after Novartis AG's generic arm Sandoz and Teva Pharmaceuticals Industries Ltd.
Wed May 01, 2013
The real cancer killer: rip-off drugs
An influential group of cancer experts has warned that the high prices charged by pharmaceutical companies for cancer drugs are effectively condemning patients to death.
Tue Apr 30, 2013
A Global Leader's Perspective on CEO Leadership: Part Two
In Part Two of my recent conversation with Dr. Vasella, the 17-year chairman and CEO of Novartis, the $60 billion life sciences industry leader, he shares some of his deep understanding of the critical value of self-awareness and introspection.
Mon Apr 29, 2013
Uncle Sam Busts Novartis AG Again
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! EAST HANOVER, N.J. /PRNewswire/ -- Novartis Pharmaceuticals Corporation disputes the allegations made by the US Attorney's Office for the Southern District of "We disagree with the way the government is characterizing our conduct in both of these matters and ... (more)
Chicago joins suit against Novartis over doctor kickbacks
The city of Chicago is among the local governments named as plaintiff in a lawsuit accusing Swiss pharmaceutical company Novartis of paying kickbacks to doctors, according to a report by Reuters.
Sun Apr 28, 2013
Wall St. Cheat Sheet
Has Novartis Been Bribing Your Doctor?
U.S. attorneys have jumped into the fray again, joining an existing lawsuit by an ex-employee of Novartis in hopes of exposing Medicare and Medicaid fraud.
Fri Apr 26, 2013
U.S. Sues Novartis Over Drug Kickbacks
U.S. federal prosecutors filed a lawsuit against Novartis Pharmaceuticals, accusing the company of paying kickbacks to doctors in an effort to encourage prescriptions for Novartis drugs.
Novartis AG Signs on to Support Malaria No More's Power of One...
Novartis AG Signs on to Support Malaria No More's Power of One Campaign to Stride Towards a Future Without Malaria /PRNewswire/ -- Novartis and Malaria No More, a leading global charity determined to end malaria deaths, announced today that they are joining forces on the Power of One campaign to help close the treatment gap and accelerate progress ... (more)
Zacks Bull and Bear of the Day Highlights: Overstock.com, Titan...
In addition, Zacks Equity Research provides analysis on Acorda Therapeutics, Inc.
Thu Apr 25, 2013
Doctors blast $100,000 cancer drugs
An annual supply of Glivec wholesales for $76,740, much more than it cost a decade ago.
More Than 16,500 Novartis Associates Worldwide Engage in Voluntary...
Today more than 16,500 Novartis associates in 56 countries are engaging in voluntary activities to help their local communities in celebration of the company's 17th Community Partnership Day .
Wed Apr 24, 2013
Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign
Every dollar donated to the Power of One campaign will fund a full course of life-saving treatment for each child diagnosed with a case of malaria.
Novartis delivered solid performance in the first quarter, with eight ...
Novartis International AG / Novartis delivered solid performance in the first quarter, with eight key regulatory approvals and all divisions contributing to growth .